Pacira Revenue Per Share from 2010 to 2024

PCRX Stock  USD 17.42  0.13  0.74%   
Pacira BioSciences, Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 10.66 in 2024. Revenue Per Share is the amount of revenue generated by Pacira BioSciences, per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
14.60295963
Current Value
10.66
Quarterly Volatility
6.36247216
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Pacira BioSciences, over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Pacira BioSciences,'s Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 15.00610 Years Trend
Pretty Stable
   Revenue Per Share   
       Timeline  

Pacira Revenue Per Share Regression Statistics

Arithmetic Mean9.24
Geometric Mean6.91
Coefficient Of Variation68.84
Mean Deviation4.51
Median8.24
Standard Deviation6.36
Sample Variance40.48
Range25.4008
R-Value0.25
Mean Square Error40.98
R-Squared0.06
Significance0.38
Slope0.35
Total Sum of Squares566.73

Pacira Revenue Per Share History

2024 10.66
2023 14.6
2022 14.65
2021 12.23
2020 9.86
2019 10.14
2018 8.24

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 14.60  10.66 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.